Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 3Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Neoplasms 2Loco-regional Esophageal Cancer 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × Esophagectomy × Clear all
NCT01372202 2019-01-25

J10130

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
31 enrolled 11 charts
Gastrointestinal

Esophageal Neoplasms

NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00570531 2016-05-26

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Terminated
6 enrolled 5 charts
Gastrointestinal

Loco-regional Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡